Oramed Pharmaceuticals (ORMP) Interest Expenses (2010 - 2026)
Oramed Pharmaceuticals (ORMP) posted Interest Expenses of $158000.0 for Q1 2026, up 28.46% on a QoQ basis from $123000.0 in Q4 2025, and up 1480.0% year-over-year from $10000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Interest Expenses (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Interest Expenses history runs 17 years deep, the most recent figure standing at $158000.0 for Q1 2026.
- Quarterly Interest Expenses rose 1480.0% year-over-year to $158000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158000.0 (up 1480.0% YoY) and the FY2025 annual result came in at $238000.0, down 99.34% from the prior year.
- Interest Expenses was $158000.0 for Q1 2026 at Oramed Pharmaceuticals, up from $123000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $1.0 million in Q2 2022 and bottomed at -$588000.0 in Q4 2024.
- A 5-year average of $331176.5 and a median of $158000.0 in 2026 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses slumped 389.66% — and 2024, when it soared 5820.0%.
- Oramed Pharmaceuticals' Interest Expenses stood at $87000.0 in 2022, then slumped by 389.66% to -$252000.0 in 2023, then tumbled by 133.33% to -$588000.0 in 2024, then soared by 120.92% to $123000.0 in 2025, then climbed by 28.46% to $158000.0 in 2026.
- Business Quant data shows ORMP's Interest Expenses at $158000.0 in Q1 2026, $123000.0 in Q4 2025, and $134000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 158,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 158,000.00 |
| Mar 31, 2026 | 158,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | -588,000.00 |
| Dec 31, 2024 | -588,000.00 |
| Sep 30, 2024 | 445,000.00 |
| Sep 30, 2024 | 445,000.00 |
| Jun 30, 2024 | 261,000.00 |
| Jun 30, 2024 | 261,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Dec 31, 2023 | -252,000.00 |
| Dec 31, 2023 | -252,000.00 |